|
Volumn 2, Issue 1, 2013, Pages
|
Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (4 CHLOROBENZYL) 3 HYDROXY 7,8,9,10 TETRAHYDROBENZO(H)QUINOLINE 4 CARBOXYLIC ACID;
2-(4-CHLOROBENZYL)-3-HYDROXY-7,8,9,10-TETRAHYDROBENZO(H)QUINOLINE-4-CARBOXYLIC ACID;
ANTITHROMBOCYTIC AGENT;
QUINOLINOL DERIVATIVE;
SELENOPROTEIN P;
ARTICLE;
BLOOD;
BLOOD CLOTTING PARAMETERS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
DRUG EFFECT;
FLOW CYTOMETRY;
HUMAN;
METABOLISM;
MONOCYTE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
SMOKING;
THROMBOCYTE;
THROMBOCYTE ADHESION;
TIME;
UNITED KINGDOM;
ADMINISTRATION, ORAL;
BLOOD PLATELETS;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FLOW CYTOMETRY;
HUMANS;
HYDROXYQUINOLINES;
MONOCYTES;
PLATELET ADHESIVENESS;
PLATELET AGGREGATION INHIBITORS;
PLATELET FUNCTION TESTS;
SCOTLAND;
SELENOPROTEIN P;
SMOKING;
TIME FACTORS;
|
EID: 84884187607
PISSN: None
EISSN: 20479980
Source Type: None
DOI: 10.1161/JAHA.112.006007 Document Type: Article |
Times cited : (24)
|
References (0)
|